Studies on the resistance of a murine leukemia L1210 cell line cis-diamminedichloroplatinum (II).
Studies on the resistance of a murine leukemia L1210 cell line cis-diamminedichloroplatinum (II).
复制标题
小鼠白血病L1210细胞系顺式二氯二氨铂(II)耐药性的研究。
DOI:
10.1016/0006-2952(81)90546-3
复制
发表时间:
1981
影响因子:
5.8
通讯作者:
Bresnick,E
中科院分区:
文献类型:
--
作者:
Eastman,A;Bresnick,E
Metal coordination complexes, particularly those of platinum, have been shown to be effective antineoplastic agents in both experimental animals and man. The most extensively investigated complex is cam-diamminedichloroplatinum (I1)(c&DDP)* whose mechanism of action has been reviewed recently [l]. cis-DDP reacts bifunctionally with DNA to form both DNA-interstrand and DNA-intrastrand cross-links as well as DNA-protein cross-links. In most previous investigations of the nature of the critical lesion (s), cis-DDP has been compared to its isomer, truns-DDP, which is ineffective as an anticancer agent. An alternative approach is made possible by the development of resistant cell lines in which the mechanism of resistance may reflect the mechanism of action of a drug. In this regard, a murine leukemia L1210 cell line (L1210IDDP) has been develoued which is resistant to concentrations’ of cis-DDP 30-iold higher than its parent cell line (L1210/0)[2]. Previous authors have reported that sublines derived from the Walker carcinoma [3] and the murine L1210 cell lines [4], both with acquired resistance to melphalan AL-phenylalanine mustard). another drug which causes DNA-intersrrand cross-links, were also cross-resistant to c&DDP. Crossresistance is not, however, as once thought to be [5], universal for all alkylating agents but instead many cell Iines exhibit variable patterns of cross-resistance [4, 6]. This communication therefore analyzes the possible cross-resistance of both cis-DDP-sensitive and-resistant Ll210 cells to a variety of DNA damaging agents. The drugs were obtained from the following sources: cti-DDP@ SC 119875). Bristol Laboratories,-Syracuse, NY: fmns-DDP and cab-dichloroethvlenediamineolatin~ m (II)(cis-DEP), Alfa Ventron, Da&em, MA; melphalan (NSC 8806), Burroughs Wellcome Co., Research Triangle Park, NC; neocarzinostatin (NSC 69856) and aziridinyl benzoquinone (NSC 1829861, Developmental Therapeutics Program, National Cancer Institute, Bethesda, MD: methyl methanesulfonate and N-methyl-N’-nitro-N-nitrosoguanidine(MNNG), Aldrich Chemical Co., Milwaukee, WI. All culture media and supplies were obtained from Gibco, Grand island, NY. A murine leukemia L121010 and a cis-DDP-resistant subline (Ll2lO/DDP) were obtained from Dr. J. Burchenal of the Sloan Kettering Institute, New York, and have been maintained in the Vermont Regional Cancer Center, University of Vermont, for 2 years. Cells were grown in plastic culture tubes in 6 ml McCoys 5a (modified) medium supplemented with penicillin, streptomycin, fungizone and 15% calf serum. Twice weekly, stock cultures of L121010 were diluted I: 11 (v/v) with fresh medium. The L12iOi DDP cells were diluted 1: 5 with fresh medium containing 2 &g/ml &DDP.Growth inhibition studies were performed by a modification of the method of Burchenal et ai.] Z]. L1210IDDP cehs were always grown for 3 days in the absence of cis-DDP to permit recovery from previous drug treatment. Cells from stock cultures were pelleted at 9OOg for 5 min